Abstract Body

Background:

Mx2 (myxovirus resistance 2), an antiviral protein whose expression is strongly upregulated by type 1 interferon, localizes to the nuclear pore complex (NPC) and inhibits HIV-1 infection by preventing nuclear import of the viral preintegration complex. The HIV-1 capsid (CA) is the major viral determinant for sensitivity to Mx2, and complex interactions between Mx2, CA, nucleoporins (Nups), cyclophilin A (CypA), and other cellular proteins influence the outcome of viral infection. Like Mx1, Mx2 is comprised of a GTPase domain connected to a carboxy-terminal stalk domain via a tripartite bundle-signaling element (BSE), however while GTPase function and higher order oligomerization are generally required for the antiviral activity of Mx1, they are dispensable for the anti-lentiviral activity of Mx2.

Methods:

To explore the interactions between Mx2, the viral CA, and CypA, we utilized a CRISPR/AAV approach to generate CypA knock-out cell lines as well as cells that express CypA from its endogenous locus, but with specific point mutations that would abrogate CA binding but should not affect enzymatic activity or cellular function.

Results:

We found that antiviral activity of Mx2 was altered in CypA mutant cell lines in a virus-specific manner, as elimination of CA-CypA interactions reduced the antiviral activity of Mx2 against HIV-1 but not HIV-2. We additionally found that infection of CypA knock-out and point mutant cell lines with wild-type HIV-1 and CA mutants recapitulated the phenotypes observed upon cyclosporine A (CsA) addition, indicating that effects of CsA treatment are the direct result of blocking CA-CypA interactions and are therefore independent from potential interactions between CypA and Mx2 or other cellular proteins. Interestingly, abrogation of GTP hydrolysis by Mx2 conferred enhanced antiviral activity when CA-CypA interactions were abolished. Elimination of GTPase activity also altered the Nup requirements for Mx2 localization and activity against wild-type HIV-1 and the G89V CA mutant which does not bind CypA.

Conclusions:

Our data demonstrate that the antiviral activity of Mx2 is affected by CypA-CA interactions in a virus-specific and GTPase activity-dependent manner. These findings further highlight the importance of the GTPase domain of Mx2 in regulation of substrate specificity and interaction with nucleocytoplasmic trafficking pathways.